ARB-272572 is a small molecule research compound that potently inhibits PD-L1 signaling by inducing its homodimerization, leading to immunostimulatory effects. It is utilized in immuno-oncology research to study immune checkpoint blockade in both cellular assays and in vivo tumor models.